GFACX
Price
$56.51
Change
-$2.32 (-3.94%)
Updated
Apr 10 closing price
Net Assets
271.59B
TSNRX
Price
$15.70
Change
-$0.65 (-3.98%)
Updated
Apr 10 closing price
Net Assets
2.07B
Ad is loading...

GFACX vs TSNRX

Header iconGFACX vs TSNRX Comparison
Open Charts GFACX vs TSNRXBanner chart's image
American Funds Growth Fund of Amer C
Price$56.51
Change-$2.32 (-3.94%)
VolumeN/A
Net Assets271.59B
Touchstone Sands Capital Select Gr R6
Price$15.70
Change-$0.65 (-3.98%)
VolumeN/A
Net Assets2.07B
GFACX vs TSNRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. TSNRX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and TSNRX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 272B vs. TSNRX (2.07B). GFACX (0.00) and TSNRX (0.00) have matching dividends . GFACX was incepted earlier than TSNRX: GFACX (24 years) vs TSNRX (5 years). GFACX (1.36) is less costly to investors than TSNRX (0.81). TSNRX is a more actively managed with annual turnover of: 41.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than TSNRX: GFACX (250) vs TSNRX (50000). TSNRX annual gain was more profitable for investors over the last year : -1.27 vs. GFACX (-3.95).
GFACXTSNRXGFACX / TSNRX
Total Expense Ratio1.360.68200%
Annual Report Gross Expense Ratio1.360.81168%
Fund Existence24 years5 years-
Gain YTD-7.732-9.16784%
Front LoadN/AN/A-
Min. Initial Investment250500001%
Min. Initial Investment IRAN/AN/A-
Net Assets272B2.07B13,166%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.95-1.27312%
Returns for 3 years4.3515.3828%
Returns for 5 years40.74N/A-
Returns for 10 years38.82N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings